CD274 and neoplasm: Notably, the identification of novel PD-L1+/PD-L2+ macrophage populations that correlate with clinical outcomes suggests that these macrophages might modulate immune responses in the TME through interactions with the T cell surface, playing a significant role in tumor progression and immune evasion (15).